| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.49 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.096 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |